CPhI Online

EuTech announces new management team additions

12 Feb 2020

EuTech has recently added two strong professionals in its Management Team. Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development.

Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development.

Shekhar Yerramilli, Chief Operating Officer

A seasoned entrepreneur and business leader, with 30 years of experience working in the Life Sciences, Technology and Finance industries. Shekkar has held positions at IQVIA (formerly IMS Health), Computer Sciences Corporation, and Citibank before starting his own entrepreneurial venture daVIZta in 2010 that serviced the Life Sciences industry's Market Access and Revenue Operations. Shekkar successfully negotiated the sale of daVIZta to world-renowned Private Equity firm Accel-KKR and subsequently merged daVIZta with IntegriChain seamlessly.

Rick Yglesias, Head of Business Development

A Pharmaceutical Quality Management Professional, and a unique people-oriented individual who has Focused on analytics and lab business intelligence, solving complex analytical issues, participating in several projects simultaneously and bringing resolution to problems across several levels. Rick brings to EuTech a proven record more than 30 years of experience in Quality Systems, Product Development support and Managing CMC submissions for drug approvals. Rick’s prior experience ranges with small to large molecules at various pharma companies including Prolong, Teva (formerly Sidmak) and GSK.

Read More